
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Familial Adenomatous Polyposis (FAP) Management: Small Bowel and Gastric Polyp Guidelines</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Familial Adenomatous Polyposis (FAP) Management: Small Bowel and Gastric Polyp Guidelines</strong></summary>
            <div>
                <ul><li>This document summarizes current recommendations for evaluating and managing small bowel polyps and fundic gland polyps (FGPs) in patients with Familial Adenomatous Polyposis (FAP).</li><li>Focuses on capsule endoscopy indications, surveillance strategies, and management of dysplastic FGPs.</li><li>Aims to provide clear, actionable guidance for physicians.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What Spigelman stages of duodenal polyposis warrant consideration for small bowel visualization in FAP patients?</li><li>2. What is the estimated lifetime risk of small bowel cancer in FAP patients, and where do most of these cancers arise?</li><li>3. What specific APC gene variants are emerging as potentially associated with increased small bowel polyp burden?</li><li>4. What percentage of FAP patients commonly present with fundic gland polyps?</li><li>5. For FAP patients with fundic gland polyps (FGPs) showing low-grade dysplasia, what polyp size threshold generally triggers endoscopic resection rather than just observation?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Small Bowel Evaluation in FAP</strong></summary>
            <div>
                <ul><li>Capsule endoscopy (CE) is recommended for specific FAP patient groups.</li><li>Not indicated for routine screening in all FAP patients.</li><li>Small bowel visualization (CE / CT/MR enterography) considered for advanced duodenal polyposis.</li></ul>
                
        <details>
            <summary><strong>Capsule Endoscopy (CE) Indications</strong></summary>
            <div>
                <ul><li>Advanced duodenal polyposis: Spigelman stage III or IV.</li><li>Consideration for duodenal surgery.</li><li>History of duodenal/ampullary cancer.</li></ul>
                
        <details>
            <summary><strong>Rationale for CE</strong></summary>
            <div>
                <ul><li>Higher prevalence of jejunal/ileal polyps in advanced duodenal disease.</li><li>Impacts surgical planning or management decisions.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Guidelines &amp; Recommendations</strong></summary>
            <div>
                <ul><li>National Comprehensive Cancer Network (NCCN) and American Society for Gastrointestinal Endoscopy (ASGE) advise consideration.</li><li>CE most strongly considered in Spigelman stage III/IV disease or prior to duodenectomy.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Surveillance Intervals</strong></summary>
            <div>
                <ul><li>Higher-risk groups: 2–4 years.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Clinical Relevance of Distal Small Bowel Polyps</strong></summary>
            <div>
                <ul><li>Uncertain: most are small, rarely progress to malignancy.</li><li>Routine surveillance in lower-risk FAP patients: not supported by current evidence.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Emerging Evidence: Genotype-Based Surveillance</strong></summary>
            <div>
                <ul><li>Certain APC gene variants (codons 278, 1062–1504) → associated w/ ↑ small bowel polyp burden.</li><li>Genotype-based surveillance: not yet standard practice.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Jejunal and Ileal Polyps in FAP</strong></summary>
            <div>
                <ul><li>Common, esp. in patients w/ advanced duodenal polyposis.</li><li>Malignant potential is low.</li><li>Routine surveillance not recommended for all FAP patients.</li></ul>
                
        <details>
            <summary><strong>Prevalence</strong></summary>
            <div>
                <ul><li>Increases w/ advanced duodenal disease (Spigelman stage III/IV).</li><li>Jejunal adenomas: up to 75% prevalence.</li><li>Ileal adenomas: up to 20% prevalence.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Malignant Potential &amp; Characteristics</strong></summary>
            <div>
                <ul><li>Most polyps: small (&lt;1 cm), lack dysplasia, rarely progress to malignancy.</li><li>Advanced lesions (&gt;1 cm or w/ high-grade dysplasia): uncommon, typically found in proximal jejunum of patients w/ advanced duodenal disease.</li><li>Lifetime risk of small bowel cancer in FAP: ≈5%, most cancers arise in the duodenum.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Management</strong></summary>
            <div>
                <ul><li>Endoscopic resection: polyps &gt;1 cm, typically using double-balloon or single-balloon enteroscopy.</li><li>Surgical intervention: rarely required, endoscopic management usually feasible.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Surveillance</strong></summary>
            <div>
                <ul><li>High-risk patients: ongoing surveillance every 2–4 years.</li><li>Low-risk patients: do not require routine small bowel surveillance.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Impact of Intervention</strong></summary>
            <div>
                <ul><li>Current evidence: does not show that ↓ jejunal/ileal polyp burden improves cancer outcomes.</li><li>Most polyps: clinically insignificant.</li><li>Impact of surveillance/intervention on long-term cancer risk: unproven; further prospective studies needed.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Fundic Gland Polyps (FGPs) in FAP</strong></summary>
            <div>
                <ul><li>Highly prevalent in FAP patients (almost 90%).</li><li>Dysplasia is common (≈50% of FGPs may be dysplastic).</li><li>Low rate of progression to high-grade dysplasia or adenocarcinoma.</li></ul>
                
        <details>
            <summary><strong>Malignancy Risk</strong></summary>
            <div>
                <ul><li>Overall lifetime risk of gastric cancer in FAP patients: &lt;1%.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Recommended Management (Low-Grade Dysplasia)</strong></summary>
            <div>
                <ul><li>Endoscopic resection: polyps ≥10 mm.</li><li>Representative sampling: smaller polyps to confirm histology.</li><li>Routine surveillance: advised for low-grade dysplasia w/o high-risk features.</li><li>General approach: observe and biopsy gastric polyps to monitor for adenomatous changes or high-grade dysplasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Surveillance Intervals (Low-Grade Dysplasia)</strong></summary>
            <div>
                <ul><li>FGPs w/ low-grade dysplasia &lt;1 cm: every 3 years.</li><li>FGPs w/ low-grade dysplasia ≥1 cm OR if not all large polyps removed in a single procedure: annually.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Surgical Indications</strong></summary>
            <div>
                <ul><li>Reserved for: multifocal high-grade dysplasia or invasive cancer.</li><li>Not for: isolated low-grade dysplasia.</li><li>Referral to expert center: recommended if lesions cannot be managed endoscopically.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>High-Risk Endoscopic Features</strong></summary>
            <div>
                <ul><li>Low-grade dysplasia alone does not require specialized surveillance/surgical intervention unless accompanied by:</li><li>Carpeting</li><li>Mounds ≥20 mm</li><li>Solitary polyps &gt;10 mm</li><li>White mucosal patches.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Upper GI Surveillance (General FAP Context)</strong></summary>
            <div>
                <ul><li>Routine upper endoscopy: every 1 to 3 years, starting @ age 18 to 25 years.</li><li>Primary surveillance target: duodenal/periampullary region.</li><li>Duodenal/periampullary region: carries much higher lifetime cancer risk (4–12%), major cause of mortality after colectomy.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
